...
机译:用苯并[Cd]吲哚-2(1H)的聚胺缀合物的发现作为溶酶体靶向抗致锑剂
Henan Univ Key Lab Nat Med &
Immunoengn Kaifeng 475004 Henan Peoples R China;
Henan Univ Key Lab Nat Med &
Immunoengn Kaifeng 475004 Henan Peoples R China;
Henan Univ Key Lab Nat Med &
Immunoengn Kaifeng 475004 Henan Peoples R China;
Henan Univ Key Lab Nat Med &
Immunoengn Kaifeng 475004 Henan Peoples R China;
Henan Univ Pharmaceut Coll Kaifeng 475004 Henan Peoples R China;
Henan Univ Coll Chem &
Chem Engn Kaifeng 475004 Henan Peoples R China;
Henan Univ Key Lab Nat Med &
Immunoengn Kaifeng 475004 Henan Peoples R China;
Henan Univ Key Lab Nat Med &
Immunoengn Kaifeng 475004 Henan Peoples R China;
Henan Univ Key Lab Nat Med &
Immunoengn Kaifeng 475004 Henan Peoples R China;
Henan Univ Key Lab Nat Med &
Immunoengn Kaifeng 475004 Henan Peoples R China;
Henan Univ Key Lab Nat Med &
Immunoengn Kaifeng 475004 Henan Peoples R China;
Henan Univ Pharmaceut Coll Kaifeng 475004 Henan Peoples R China;
Henan Univ Key Lab Nat Med &
Immunoengn Kaifeng 475004 Henan Peoples R China;
机译:用苯并[Cd]吲哚-2(1H)的聚胺缀合物的发现作为溶酶体靶向抗致锑剂
机译:发现苯并[CD] Indol-2(1H) - 氨基和吡咯[4,3,2-DE]喹啉-2(1H) - 作为溴琼瘤和额外末端结构域(BET)抑制剂,具有第一溴γ的选择性 对急性痛风性关节炎的潜在高效率
机译:苯并[cd] indol-2(1H)-作为强效和特定BET溴结构域抑制剂的发现:基于结构的虚拟筛选,优化和生物学评价。
机译:将二烷基锌试剂催化对映选择性共轭加成至α,β-不饱和羰基的新方法:发现和使用新催化剂。
机译:合理发现靶向MBD2内在无序区域的抗肿瘤药
机译:修正的结构,苯并[cd]吲哚-2(1H)-1,用于带有乙炔的1-取代的环庚[b]吡咯-2(1H)-1的环缩合环加合物